Clinical Trial Detail

NCT ID NCT01336842
Title Study of Cisplatin and Pemetrexed in Combination With Panobinostat in Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of California, Davis
Indications

Advanced Solid Tumor

lung non-small cell carcinoma

Therapies

Cisplatin

Panobinostat

Pemetrexed Disodium

Age Groups: adult senior

No variant requirements are available.